Genitourinary malignancy among patients presenting with microscopic hematuria in Northwestern Ontario

Read full text Summarise with VIRAT
Authors: Shahrzad Keramati, Ahmed Eed Ibrahim Mousa, Moustafa Fathy, Vahid Mehrnoush, Mark Tatangelo, Neda Ghaffarimarandi, Salima Oukachbi, Mohammed Bassuony, Farah Labib, Dina S. Shaker, Abdalla Bazazo, Ahmed Sayed Zakaria
+4 more Ahmed Kotb, Kristen A. Morin, David Marsh, Hazem M. Elmansy
Cited by: 0
References: 42

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Microscopic hematuria (MH) may indicate an underlying genitourinary (GU) malignancy. Accordingly, MH workup is essential to mitigate GU cancer-related morbidity and mortality. This study aimed to evaluate the etiologies of MH in Northwestern Ontario, Canada. METHODS: We conducted a retrospective cohort chart review of 2545 patients referred to our institution for MH from 2010-2020. Demographic and clinical data were collected. Low- and high-grade MH were defined as ≤25 and >25 red blood cells (RBCs) per high-power field (HPF), respectively. RESULTS: The prevalence of GU cancer was 5.2% among patients with MH; the majority of cases (108/133, 81.2%) were identified during the initial workup, with urothelial carcinoma of the bladder being the most common subtype (81.2%). GU cancer was significantly associated with male sex (odds ratio [OR] 2.958, p

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Urological Disorders and Treatments

Publication details

Journal / source
Canadian Urological Association Journal
Volume
20
Issue
8
Pages
248–255
Publication date
30 March 2026
Language
EN